Why is Medplus Health Services Ltd falling/rising?

Recent Price Movement and Market Context

Medplus Health’s stock has been under pressure for the past two trading sessions, registering a cumulative loss of approximately 2.49%. On 19-Feb, the stock touched an intraday low of ₹825, reflecting a 2.53% drop from previous levels. This decline is somewhat in line with the broader sector’s performance, indicating that the stock’s movement is not isolated but influenced by sector-wide trends. However, when compared to the benchmark Sensex, which declined by 1.41% over the past week, Medplus’s one-week return of -3.19% suggests a relatively weaker short-term performance.

Despite this recent softness, the stock has demonstrated resilience over longer periods. Year-to-date, it has gained 2.75%, outperforming the Sensex’s negative 3.19% return. Over the past year, Medplus has delivered a 9.00% return, marginally ahead of the Sensex’s 8.64%. This indicates that while short-term volatility is evident, the stock maintains a positive trajectory over extended horizons.

Technical Indicators and Investor Behaviour

From a technical standpoint, the stock’s price currently sits above its 50-day and 100-day moving averages, signalling underlying medium-term strength. However, it remains below its 5-day, 20-day, and 200-day moving averages, suggesting some near-term weakness and potential resistance levels. This mixed technical picture may be contributing to investor caution.

Investor participation appears to be waning, as evidenced by a significant 37.74% drop in delivery volume on 18-Feb compared to the five-day average. The delivery volume stood at 62,140 shares, indicating reduced conviction among buyers. This decline in investor engagement could be a factor behind the recent price softness, as lower participation often leads to increased volatility and downward pressure.

Strong Financial Performance Supports Valuation

Medplus Health Services has reported positive results for six consecutive quarters, underscoring its operational consistency. The company’s return on capital employed (ROCE) for the half-year period stands at an impressive 11.47%, reflecting efficient utilisation of capital. Additionally, the inventory turnover ratio is high at 4.91 times, indicating effective inventory management and strong sales velocity.

Quarterly net sales have reached a peak of ₹1,806.12 crores, highlighting robust revenue growth. Over the past year, profits have surged by 56.4%, a remarkable increase that supports the stock’s attractive valuation metrics. The company’s enterprise value to capital employed ratio is 4.2, suggesting it is trading at a discount relative to its peers’ historical averages. Furthermore, the price-to-earnings-to-growth (PEG) ratio of 0.9 indicates that the stock is reasonably valued given its earnings growth prospects.

These fundamentals provide a strong foundation for the stock, making it a hold for investors who prioritise long-term growth and value. However, the recent price decline reflects short-term market dynamics rather than any fundamental deterioration.

Liquidity and Trading Considerations

Liquidity remains adequate for Medplus Health, with the stock’s traded value supporting a trade size of approximately ₹0.27 crores based on 2% of the five-day average traded value. This level of liquidity ensures that investors can enter and exit positions without significant price impact, although the recent drop in delivery volume suggests some hesitation among market participants.

In summary, the recent decline in Medplus Health Services Ltd’s share price on 19-Feb is primarily driven by short-term market and sector pressures, coupled with reduced investor participation. Despite this, the company’s strong financial performance, attractive valuation, and consistent growth record provide a solid basis for holding the stock. Investors should weigh these fundamentals against the current market sentiment when making decisions.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →